用于治疗阿尔茨海默病的阿杜卡努单抗：加速批准与延缓科学进程 - Suppr

Suppr

超能文献

Aducanumab for Alzheimer's disease: expediting approval and delaying science.

作者信息

Salinas Rodrigo A

机构信息

Departamento de Ciencias Neurológicas, Universidad de Chile, Santiago de Chile, Chile

出版信息

BMJ Evid Based Med. 2021 Oct;26(5):214-215. doi: 10.1136/bmjebm-2021-111765. Epub 2021 Jul 14.

DOI:10.1136/bmjebm-2021-111765

PMID:34261765

Abstract

摘要

相似文献

Aducanumab for Alzheimer's disease: expediting approval and delaying science.

BMJ Evid Based Med. 2021 Oct;26(5):214-215. doi: 10.1136/bmjebm-2021-111765. Epub 2021 Jul 14.

[Aducanumab approval for Alzheimer's disease in the USA: the surrender of science].

Rev Neurol. 2021 Oct 16;73(8):296-297. doi: 10.33588/rn.7308.2021378.

Aducanumab: First Approval.

Drugs. 2021 Aug;81(12):1437-1443. doi: 10.1007/s40265-021-01569-z.

Aducanumab for Alzheimer's disease?

BMJ. 2021 Jul 5;374:n1682. doi: 10.1136/bmj.n1682.

How the US Food and Drug Administration's approval of aducanumab for Alzheimer's disease has implication for oncology and beyond.

Eur J Cancer. 2021 Nov;157:68-70. doi: 10.1016/j.ejca.2021.08.012. Epub 2021 Sep 4.

Alzheimer's disease: the controversial approval of Aducanumab.

Neurol Sci. 2021 Aug;42(8):3069-3070. doi: 10.1007/s10072-021-05497-4. Epub 2021 Jul 29.

The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.

J Alzheimers Dis. 2021;82(3):881-882. doi: 10.3233/JAD-210736.

Aducanumab for Alzheimer's disease: A regulatory perspective.

Pharmacol Res. 2021 Sep;171:105754. doi: 10.1016/j.phrs.2021.105754. Epub 2021 Jul 2.

Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data.

J Alzheimers Dis. 2021;84(4):1457-1460. doi: 10.3233/JAD-215275.

Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab.

N Engl J Med. 2021 Aug 26;385(9):771-774. doi: 10.1056/NEJMp2111320. Epub 2021 Jul 28.

引用本文的文献

Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies.

Mol Neurobiol. 2025 Feb;62(2):2314-2332. doi: 10.1007/s12035-024-04384-1. Epub 2024 Aug 5.

A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer's Disease.

Med Sci Monit. 2024 May 13;30:e945091. doi: 10.12659/MSM.945091.

Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer's disease.

CNS Neurosci Ther. 2022 Apr;28(4):580-592. doi: 10.1111/cns.13779. Epub 2021 Dec 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Aducanumab for Alzheimer's disease: expediting approval and delaying science.

BMJ Evid Based Med. 2021 Oct;26(5):214-215. doi: 10.1136/bmjebm-2021-111765. Epub 2021 Jul 14.

[Aducanumab approval for Alzheimer's disease in the USA: the surrender of science].

Rev Neurol. 2021 Oct 16;73(8):296-297. doi: 10.33588/rn.7308.2021378.

Aducanumab: First Approval.

Drugs. 2021 Aug;81(12):1437-1443. doi: 10.1007/s40265-021-01569-z.

Aducanumab for Alzheimer's disease?

BMJ. 2021 Jul 5;374:n1682. doi: 10.1136/bmj.n1682.

How the US Food and Drug Administration's approval of aducanumab for Alzheimer's disease has implication for oncology and beyond.

Eur J Cancer. 2021 Nov;157:68-70. doi: 10.1016/j.ejca.2021.08.012. Epub 2021 Sep 4.

Alzheimer's disease: the controversial approval of Aducanumab.

Neurol Sci. 2021 Aug;42(8):3069-3070. doi: 10.1007/s10072-021-05497-4. Epub 2021 Jul 29.

The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.

J Alzheimers Dis. 2021;82(3):881-882. doi: 10.3233/JAD-210736.

Aducanumab for Alzheimer's disease: A regulatory perspective.

Pharmacol Res. 2021 Sep;171:105754. doi: 10.1016/j.phrs.2021.105754. Epub 2021 Jul 2.

Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data.

J Alzheimers Dis. 2021;84(4):1457-1460. doi: 10.3233/JAD-215275.

Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab.

N Engl J Med. 2021 Aug 26;385(9):771-774. doi: 10.1056/NEJMp2111320. Epub 2021 Jul 28.

引用本文的文献

Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies.

Mol Neurobiol. 2025 Feb;62(2):2314-2332. doi: 10.1007/s12035-024-04384-1. Epub 2024 Aug 5.

A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer's Disease.

Med Sci Monit. 2024 May 13;30:e945091. doi: 10.12659/MSM.945091.

Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer's disease.

CNS Neurosci Ther. 2022 Apr;28(4):580-592. doi: 10.1111/cns.13779. Epub 2021 Dec 10.